FDA Asks Ariad to Halt Sale of Leukemia Drug

WASHINGTON (MedPage Today) -- The FDA has asked Ariad Pharmaceuticals to suspend marketing and sales of Iclusig (ponatinib), a chemotherapy agent used to treat leukemia, pending further investigation of reports of "life-threatening blood clots and severe narrowing of blood vessels". via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/10/fda-asks-ariad-to-halt-sale-of-leukemia.html